Literature DB >> 9362244

Cardiovascular responses to dynamic exercise with acute anemia in humans.

M D Koskolou1, R C Roach, J A Calbet, G Rådegran, B Saltin.   

Abstract

We hypothesized that reducing arterial O2 content (CaO2) by lowering the hemoglobin concentration ([Hb]) would result in a higher blood flow, as observed with a low PO2, and maintenance of O2 delivery. Seven young healthy men were studied twice, at rest and during two-legged submaximal and peak dynamic knee extensor exercise in a control condition (mean control [Hb] 144 g/l) and after 1-1.5 liters of whole blood had been withdrawn and replaced with albumin [mean drop in [Hb] 29 g/l (range 19-38 g/l); low [Hb]]. Limb blood flow (LBF) was higher (P < 0.01) with low [Hb] during submaximal exercise (i.e., at 30 W, LBF was 2.5 +/- 0.1 and 3.0 +/- 0.1 l/min for control [Hb] and low [Hb], respectively; P < 0.01), resulting in a maintained O2 delivery and O2 uptake for a given workload. However, at peak exercise, LBF was unaltered (6.5 +/- 0.4 and 6.6 +/- 0.6 l/min for control [Hb] and low [Hb], respectively), which resulted in an 18% reduction in O2 delivery (P < 0.01). This occurred despite peak cardiac output in neither condition reaching >75% of maximal cardiac output (approximately 26 l/min). It is concluded that a low CaO2 induces an elevation in submaximal muscle blood flow and that O2 delivery to contracting muscles is tightly regulated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362244     DOI: 10.1152/ajpheart.1997.273.4.H1787

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  19 in total

1.  Polymorphisms in the HBB gene relate to individual cardiorespiratory adaptation in response to endurance training.

Authors:  Z He; Y Hu; L Feng; Y Lu; G Liu; Y Xi; L Wen; X Xu; K Xu
Journal:  Br J Sports Med       Date:  2006-09-21       Impact factor: 13.800

2.  Erythrocytes and the regulation of human skeletal muscle blood flow and oxygen delivery: role of erythrocyte count and oxygenation state of haemoglobin.

Authors:  José González-Alonso; Stefan P Mortensen; Ellen A Dawson; Niels H Secher; Rasmus Damsgaard
Journal:  J Physiol       Date:  2006-01-26       Impact factor: 5.182

Review 3.  The exercising heart at altitude.

Authors:  José A L Calbet; Paul Robach; Carsten Lundby
Journal:  Cell Mol Life Sci       Date:  2009-10-07       Impact factor: 9.261

Review 4.  Local control of skeletal muscle blood flow during exercise: influence of available oxygen.

Authors:  Darren P Casey; Michael J Joyner
Journal:  J Appl Physiol (1985)       Date:  2011-09-01

5.  The effects of beta1-adrenergic blockade on cardiovascular oxygen flow in normoxic and hypoxic humans at exercise.

Authors:  Guido Ferretti; Marc J Licker; Sara Anchisi; Christian Moia; Davide Susta; Denis R Morel
Journal:  Eur J Appl Physiol       Date:  2005-10-01       Impact factor: 3.078

Review 6.  Disparity in regional and systemic circulatory capacities: do they affect the regulation of the circulation?

Authors:  J A L Calbet; M J Joyner
Journal:  Acta Physiol (Oxf)       Date:  2010-03-25       Impact factor: 6.311

7.  Exercising skeletal muscle blood flow in humans responds to reduction in arterial oxyhaemoglobin, but not to altered free oxygen.

Authors:  J Gonzalez-Alonso; R S Richardson; B Saltin
Journal:  J Physiol       Date:  2001-01-15       Impact factor: 5.182

Review 8.  Skeletal muscle vasodilatation during maximal exercise in health and disease.

Authors:  Jose A L Calbet; Carsten Lundby
Journal:  J Physiol       Date:  2012-10-01       Impact factor: 5.182

9.  Muscle blood flow is reduced with dehydration during prolonged exercise in humans.

Authors:  J González-Alonso; J A Calbet; B Nielsen
Journal:  J Physiol       Date:  1998-12-15       Impact factor: 5.182

10.  On the mechanisms that limit oxygen uptake during exercise in acute and chronic hypoxia: role of muscle mass.

Authors:  José A L Calbet; Göran Rådegran; Robert Boushel; Bengt Saltin
Journal:  J Physiol       Date:  2008-12-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.